**Author details**

Biba Vikas1 \* and Sukumaran Anil<sup>2</sup>

1 Jawaharlal Nehru Tropic Botanical Garden and Research Institute, Trivandrum, India

2 Department of Dentistry, Hamad Medical Corporation, Doha, Qatar

\*Address all correspondence to: bibavikas@gmail.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**115**

1980/01/01]

*Cell-Based Assays in Cancer Research*

**References**

*DOI: http://dx.doi.org/10.5772/intechopen.90226*

[1] Godbey WT. In: Godbey WT, editor. An Introduction to Biotechnology. Woodhead Publishing; 2014. pp. 107-142. DOI: 10.1016/ b978-1-907568-28-2.00005-8

ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/ TRAIL). Journal of Clinical Oncology. 2008;**26**:3621-3630. DOI: 10.1200/ JCO.2007.15.7198. [Epub 2008/07/22]

[9] Elmore S. Apoptosis: a review of programmed cell death. Toxicologic Pathology. 2007;**35**:495-516. DOI: 10.1080/01926230701320337. [Epub

[11] Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. The New England Journal of Medicine. 1996;**334**:1717-1725. DOI: 10.1056/NEJM199606273342607. [Epub

[12] Roy S, Nicholson DW. Cross-talk in cell death signaling. Journal of Experimental Medicine. 2000;**192**:F21-

[13] Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer. 1972;**26**:239-257. DOI: 10.1038/bjc.1972.33. [Epub 1972/08/01]

[14] Wyllie AH. What is apoptosis? Histopathology. 1986;**10**:995-998 [Epub

[15] Fey SJ, Wrzesinski K. Determination of drug toxicity using 3D spheroids constructed from an immortal human hepatocyte cell line. Toxicological Sciences. 2012;**127**:403-411. DOI:

10.1093/toxsci/kfs122. [Epub 2012/03/29]

[16] Breslin S, O'Driscoll L. Threedimensional cell culture: The missing link in drug discovery. Drug Discovery

[10] Lane D. Anthony Dipple carcinogenesis award. P53 from pathway to therapy. Carcinogenesis. 2004;**25**:1077-1081. DOI: 10.1093/ carcin/bgh186. [Epub 2004/06/19]

2007/06/15]

1996/06/27]

1986/09/01]

F25 [Epub 2000/10/18]

[2] Holland P, Nielsen J, Mondeel TDGA, Barberis M. Coupling cell division to metabolic pathways through transcription. In: Ranganathan S, Gribskov M, Nakai K, Schönbach C, editors. Encyclopedia of Bioinformatics and Computational Biology. Oxford: Academic Press; 2019. p. 74-93. DOI: 10.1016/B978-0-12-809633-8.20081-2

[3] Paweletz N. Walther flemming: Pioneer of mitosis research. Nature Reviews Molecular Cell Biology. 2001;**2**:72-75. DOI: 10.1038/35048077.

[4] Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature. 2004;**432**:307-315. DOI: 10.1038/ nature03098. [Epub 2004/11/19]

[5] Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;**411**:342-348. DOI: 10.1038/35077213. [Epub 2001/05/18]

[6] Kamsteeg M, Rutherford T, Sapi E, Hanczaruk B, Shahabi S, Flick M, et al. Phenoxodiol—An isoflavone analog— Induces apoptosis in chemoresistant ovarian cancer cells. Oncogene.

2003;**22**:2611-2620. [Epub 2003/05/06].

[7] Wyllie AH, Kerr JF, Currie AR. Cell death: The significance of apoptosis, International Review of Cytology. 1980;**68**:251-306. DOI: 10.1016/ s0074-7696(08)62312-8. [Epub

Eckhardt SG. Ligand-based targeting of apoptosis in cancer: The potential of recombinant human apoptosis

DOI: 10.1038/sj.onc.1206422

[8] Ashkenazi A, Holland P,

[Epub 2001/06/20]
